Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-400
Closed -$31.7K 98
2025
Q2
$31.7K Hold
400
0.03% 84
2025
Q1
$35.9K Hold
400
0.03% 82
2024
Q4
$39.8K Hold
400
0.04% 78
2024
Q3
$45.4K Hold
400
0.04% 71
2024
Q2
$49.5K Hold
400
0.05% 74
2024
Q1
$52.8K Hold
400
0.05% 72
2023
Q4
$43.6K Hold
400
0.04% 84
2023
Q3
$41.2K Hold
400
0.04% 74
2023
Q2
$46.2K Hold
400
0.04% 71
2023
Q1
$42.6K Hold
400
0.04% 80
2022
Q4
$44.4K Hold
400
0.04% 77
2022
Q3
$34K Hold
400
0.04% 93
2022
Q2
$36K Hold
400
0.03% 102
2022
Q1
$33K Hold
400
0.03% 96
2021
Q4
$31K Hold
400
0.02% 98
2021
Q3
$30K Hold
400
0.02% 98
2021
Q2
$31K Buy
400
+190
+90% +$14.1K 0.02% 90
2021
Q1
$15K Hold
210
0.01% 92
2020
Q4
$16K Buy
+210
New +$16.1K 0.02% 85

Other funds holding MRK

Park Circle Company's MRK Position: Q3 2025 in Review

Park Circle Company sold out of Merck (MRK) in Q3 2025, closing a stake of 400 shares — an estimated $31.7K sold.

Park Circle Company first reported a position in MRK in Q4 2020 and held it in 19 quarters. The position peaked at $52.8K in Q1 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Park Circle Company reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Park Circle Company sold 400 Merck shares in Q3 2025, an estimated $31.7K.
  • Park Circle Company first reported a position in Merck in Q4 2020 and held it in 19 quarters.
  • Park Circle Company's Merck position peaked at $52.8K in Q1 2024.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Park Circle Company's 13F filing for Q3 2025, filed 7 Nov 2025.